Pat Mackin appointed as a company director of Opsens

193

Opsens, which has an advanced optical-based pressure guidewire (OptoWire) that aims at improving the clinical outcome of patients with coronary artery disease, has announced the appointment of Pat Mackin as a director of the company. A press release reports that Mackin has more than 25 years of experience in the medical device industry and has been president and chief executive officer of CryoLife since September 2014.

Before joining CryoLife, he was president of the Cardiac Rhythm Disease Management Division at Medtronic and, prior to that, held the positions of vice president, Vascular, Western Europe and vice president and general manager, Endovascular Business Unit at the company. Prior to joining Medtronic, Mackin worked for six years at Genzyme (serving as senior vice president and general manager for the Cardiovascular Surgery Business Unit and as director of Sales, Surgical Products division), five years at Deknatel/Snowden-Pencer (in various sales and marketing roles), and three years as an officer in the US army.

Louis Laflamme, president and chief executive officer of Opsens, says: “We are delighted to see Pat, a renowned leader in the medical device industry, join us. His expertise as head of leading companies in the cardiovascular space will be valuable as we step up from limited market release to a wider one.”